Thank you, operator and welcome everyone to today's call. I'm going to start with third quarter financial highlights and then discuss our three business segments. After that, I'll hand it over to Mike, who will walk us through a more detailed financial discussion, as well as our outlook for the rest of the year. When Mike is done, we'll open the call for your questions. Our overall third quarter performance improved versus the second quarter as well as the year earlier quarter with top line growth and greater profitability. While we still sense some hesitancy on the part of customers given the uncertainty that's existed all year around inflation, interest rates, the presidential election and geopolitical conflicts, we achieved the acceleration over the first half results that we spoke about on our Q2 call. You might recall that we contemplated the benefit of the revenue shift into the third quarter, resulting from the second quarter supply chain issues. We continue to execute internally to make the most of these still somewhat soft market conditions. On a consolidated basis, we produced revenues of $150 million, up 10% versus the year ago period, driven by double-digit growth in both health care apparel and branded products. We are proud to say that these are the highest quarterly revenues ever achieved in our core products and services. The only other time we have ever slightly exceeded this was in Q2 2020 when our revenues were largely made up of PPE in response to the early stages of the pandemic. EBITDA of $11.7 million was up 26% from $9.3 million and our EBITDA margin expanded a full percentage point to 7.8%. Breaking this down further, our gross margin percentage climbed 130 basis points over the prior year and we were able to hold SG&A as a percent of sales almost flat at 34.9%, which includes the growth-oriented investments mentioned in prior quarters. Putting this all together, our third quarter diluted EPS rose to $0.33 from $0.19 a year earlier. On top of all this good news, we also continue to strengthen our financial foundation by generating another quarter of positive operating cash flow, which allowed us to improve our already strong net leverage ratio. Going forward, our financial strength will allow us to continue our strategic investments to capitalize on the compelling growth opportunities within our three very attractive end markets. Before turning to a discussion around our segments, I'll reiterate what I mentioned on prior calls. From a big picture standpoint, Superior Group Company still has a very small, but expanding share of three large growing and highly fragmented end markets. We are intelligently investing in our people services products and technology to continue to take more than our share of new customers with an emphasis as always on excellent retention of existing customers. Now, let's shift to our business segments, starting with Healthcare Apparel. Our third quarter revenue was up 11% versus the prior year quarter, benefiting from growth in our online channels, both wholesale and direct-to-consumer, despite continued soft market conditions in the wholesale channel of our business selling to health care apparel retail stores. Our third quarter revenue also benefited from the timing of revenues as compared to last year due in part to the supply chain issues in Q2 that we already mentioned. The increase in our gross margin percentage of more than 300 basis points was partially offset by an increase in SG&A as a percentage of sales of 200 basis points. While the SG&A rate was at its best level so far in 2024, the rate did increase year-over-year, mostly due to sales and marketing investments to drive awareness of the Wink brand and to support our online channels as well as continued investments in top talent. As a result our EBITDA in our Healthcare Apparel segment of $3.8 million was up from the year ago $3.1 million. Let's move on to our Branded Products segment which also achieved revenue growth of 11% compared to last year. The revenue increase was mostly driven by increased volume with existing customers including the revenue shift discussed earlier as well as the addition of many new customers. For now, we're taking market share by adding new customers, which is helping to offset some legacy customers largely coming in with smaller orders and which we believe will further fuel our growth once the environment improves. Overall, the business has played out as indicated on our prior call. Similar to the second quarter, demand trends were reasonably solid, even though there's still a fair amount of customer caution. In addition to the top line growth during the quarter, our gross margin expanded 160 basis points and we were also able to reduce SG&A as a percentage of sales by 180 basis points. As a result, our EBITDA was up more than 50% over the prior year to $10.7 million and our EBITDA margin expanded more than three percentage points. Next up is Contact Centers our highest margin segment which had a 4% year-over-year sales increase driven by new customers, partially offset by lower sales from existing customers. Our investments in talent and satellite offices to support future organic growth are reflected in our healthy win rate and pipeline of new business, but are also currently affecting our gross margin and SG&A. As a result, our EBITDA was $3 million versus $4.1 million in the prior year period. Our longer-term strategy for contact centers is to grow our customer count catering to small and medium-sized enterprises. In addition to significantly launching and growing our sales team and increasing our marketing spend we're also deploying the very latest technology to benefit the customer experience, enhance our efficiencies and competitive edge, and to profitably grow over time. With that, I'll turn it over to Mike, who will take us through our third quarter results in detail and update you on our full year outlook. Mike?